|
SNAP23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.641600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.060200E-01 |
| Normal-vs-Stage2 |
7.323800E-01 |
| Normal-vs-Stage3 |
5.742000E-01 |
| Normal-vs-Stage4 |
5.546600E-01 |
| Stage1-vs-Stage2 |
2.921600E-01 |
| Stage1-vs-Stage3 |
6.893000E-01 |
| Stage1-vs-Stage4 |
7.218200E-01 |
| Stage2-vs-Stage3 |
4.756400E-01 |
| Stage2-vs-Stage4 |
4.550200E-01 |
| Stage3-vs-Stage4 |
9.674000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.715800E-01 |
| Normal-vs-AfricanAmerican |
6.641200E-03 |
| Normal-vs-Asian |
9.818000E-01 |
| Caucasian-vs-AfricanAmerican |
1.147750E-02 |
| Caucasian-vs-Asian |
8.685600E-01 |
| AfricanAmerican-vs-Asian |
2.527600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.893200E-01 |
| Normal-vs-Female |
1.795410E-01 |
| Male-vs-Female |
3.405600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.760200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.420400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.873600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.188400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.291400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.719000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.769000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.080800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.133800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.915200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.675400E-01 |
| Normal-vs-Grade 2 |
6.474600E-01 |
| Normal-vs-Grade 3 |
1.643600E-01 |
| Normal-vs-Grade 4 |
7.518800E-01 |
| Grade 1-vs-Grade 2 |
3.633600E-01 |
| Grade 1-vs-Grade 3 |
1.273440E-01 |
| Grade 1-vs-Grade 4 |
3.443600E-01 |
| Grade 2-vs-Grade 3 |
3.580000E-01 |
| Grade 2-vs-Grade 4 |
9.709200E-01 |
| Grade 3-vs-Grade 4 |
4.421800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.474200E-01 |
| Normal-vs-ccB subtype |
3.772200E-01 |
| ccA subtype-vs-ccB subtype |
1.207760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.977000E-01 |
| Normal-vs-N1 |
4.639200E-01 |
| N0-vs-N1 |
3.751400E-01 |
|
|
